The highly-expressed PD-L1 on tumors was demonstrated to induce anti-tumor immune inhibition by promoting the apoptosis of antigen-specific and tumor-reactive T cells 41 and the PD-1/PD-L1 axis could enhance invasion of GBM cells in brain 42. This evidence concerns the gene PDCD1 and glioblastoma.